Tech Company Financing Transactions

Trubion Pharmaceuticals Funding Round

On 3/31/2005, Trubion Pharmaceuticals landed $12 million in funding from Arch Venture Partners, Frazier Healthcare Partners and Oxford Bioscience Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

2401 4th Ave 1050
Seattle, WA 98121
USA

Phone

(206) 838-0500

Website

www.trubion.com

Email Address

[email protected]

Overview

Trubion Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat inflammatory disease and cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Steven Gillis

        

Chief Financial Officer

Michelle Burris

        

Chief Medical Officer

Scott Stromatt

        

VP - General Counsel

Kathleen Deeley

        

VP - R & D

Kendall Mohler

        

Browse more venture capital transactions:

Prev: 3/31/2005: Motion Computing venture capital transaction
Next: 3/31/2005: Webroot Software venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary